Clinical Trials for RAS/BRAF Wild-type Advanced Colorectal Cancer Patients

Find clinical trials for ras/braf wild-type advanced colorectal cancer patients. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

An Open-label, Single-arm, Multicenter Phase II Study to Evaluate the Efficacy of Amivantamab in Combination With FOLFIRI as a Second-line Treatment in Patients With RAS/BRAF Wild-type Advanced Colorectal Cancer Progressing on Prior Anti-EGFR Based Treatment.

NCT ID: NCT06855849

This clinical trial is exploring the effectiveness of a new treatment called amivantamab combined with a standard chemotherapy regimen called FOLFIRI for patients with advanced colorectal cancer. T...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Seoul, , Korea, Republic Of

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions